Prolife Chemopharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 8.29 M
as on 23-10-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.26 Cr
as on 23-10-2024
- Satisfied Charges ₹ 10.89 Cr
as on 23-10-2024
- Revenue -35.14%
(FY 2023)
- Profit -22.29%
(FY 2023)
- Ebitda -14.89%
(FY 2023)
- Net Worth 51.00%
(FY 2023)
- Total Assets -12.48%
(FY 2023)
About Prolife Chemopharma
The Corporate was formerly known as Prolife Pharmachem Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.29 M.
The company currently has active open charges totaling ₹11.26 Cr. The company has closed loans amounting to ₹10.89 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kishorbhai Kheni, Anureet Jolly, Chetan Chandrakant, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ2005PTC045431
- Company No.
045431
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Feb 2005
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Prolife Chemopharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kishorbhai Kheni  | Director | 10-Mar-2007 | Current |
| Karan Jolly | Director | 12-Feb-2019 | Current |
| Anureet Jolly | Director | 15-May-2021 | Current |
| Chetan Chandrakant | Director | 15-Apr-2017 | Current |
| Vivek Rakeshbhai | Director | 17-Oct-2016 | Current |
Financial Performance of Prolife Chemopharma.
Prolife Chemopharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 35.14% decrease. The company also saw a substantial fall in profitability, with a 22.29% decrease in profit. The company's net worth Soared by an impressive increase of 51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prolife Chemopharma?
In 2023, Prolife Chemopharma had a promoter holding of 99.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prolife Hair And Health Care Private LimitedActive 9 years 2 monthsAnureet Jolly and Karan Jolly are mutual person
Prolife Communication Private LimitedActive 8 years 11 monthsAnureet Jolly and Karan Jolly are mutual person
- Prolife Multi Specialty Hospitals Private LimitedActive 8 years 10 months
Anureet Jolly and Karan Jolly are mutual person
- Prolife Bio-Chemical Industries Private LimitedActive 30 years 3 months
Anureet Jolly, Chetan Chandrakant and 1 more are mutual person
- Goldstar Chemicals Private LimitedActive 37 years 1 month
Chetan Chandrakant and Karan Jolly are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Aug 2021 | ₹6.80 M | Open |
Others Creation Date: 25 Mar 2021 | ₹4.95 Cr | Open |
Others Creation Date: 17 Dec 2020 | ₹6.80 M | Open |
How Many Employees Work at Prolife Chemopharma?
Prolife Chemopharma has a workforce of 23 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prolife Chemopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prolife Chemopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
